跳至主要内容
临床试验/NCT03025919
NCT03025919Unknown不适用

Using 2h-glycosuria Combined With Fasting Plasma Glucose , Advanced Glycation End-product Alone or in Combination With Fasting Plasma Glucose in Diabetes Screening in Chinese Natural Population

Zhongda Hospital1 个研究点 分布在 1 个国家目标入组 20,000 人开始时间: 2017年1月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
20,000
试验地点
1
主要终点
area under the ROC curve

研究概览

简要总结

Evaluation of using 2h-UG combined with FPG, AGEsP alone or in combination with FPG in diabetes screening in Chinese natural population

详细描述

Using the WHO criteria as the golden standard,drawing the ROC curve of 2h-UG combined with FPG, AGEsP alone or in combination with FPG,calculating the area under the ROC curve.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Cross Sectional

入排标准

年龄范围
12 Years 至 70 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 20~70 year old urban and rural residents;
  • Volunteer to participate in this study and sign informed consent.

排除标准

  • 未提供

结局指标

主要结局

area under the ROC curve

时间窗: 6 months

area under the ROC curve of different method of using 2h-UG combined with FPG, AGEsP alone or in combination with FPG in diabetes screening in Chinese natural population

次要结局

  • sensitivity and specificity of screening(6 months)

研究者

发起方
Zhongda Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Zilin Sun

director physician

Zhongda Hospital

研究点 (1)

Loading locations...

相似试验

Evaluation of Innovated Screening Tools for Type 2... | 临床试验